Events and News

Associate Professor Christopher Chen, senior consultant at the Department of Psychological Medicine at the National University Hospital of Singapore (NUH), said in an interview with Lianhe Zaobao that although this research is good news for the treatment of Alzheimer’s disease, there remains much work to do before we ultimately develop a complete cure for Alzheimer’s disease. .”If we 

The MACC director believes that current drugs for treating Alzheimer’s Disease mainly slow down the progression of the disease, and it is unrealistic to develop a cure ifor advanced disease. Therefore, prevention and medical intervention in the early stages remain important approaches to treating such diseases. The MACC is currently conducting clinical trials of drugs and multiple lifestyle interventions so as to prevent cognitive impairment and dementia, one of the ongoing studies is the AHEAD study that tests whether applying interventions ahead of symptoms could prevent future memory loss and dementia.

Read more here: https://www.zaobao.com.sg/news/singapore/story20231214-1456185

Read the StraitTime article: Exercise to boost brain functions, fight dementia

Watch the 8 World Video: here 

If you are interested in the SINGER study, you may read more here.

In this episode, host Germaine Tan gets the low-down on a new drug for those with Alzheimer’s disease, learns how Asian dementia differs from the west and how murals on flats can help. She also gets her hands on a new therapy tool designed to jog the memory of elderly folks. And does writing things down help you remember them better? Germaine puts herself to the test!

Watch the full episode here: https://www.youtube.com/watch?v=sZa2sQXw5g0&ab_channel=CNAInsider

Patients with Alzheimer’s disease – the most common cause of dementia – may soon get a new drug that can slow progression of the disease, a recent study has found. The MACC is the only dementia research center in Singapore that helped to recruit subjects for this international clinical trial, which subjects were given the drug known as lecanemab, and was found to be at least six months behind those who received a placebo after 18 months of treatment.

Read more below:

English: https://www.straitstimes.com/singapore/health/experimental-alzheimer-s-drug-can-slow-progression-of-disease-nuh

Mandarin: https://www.8world.com/singapore/alzheimer-new-medicine-1994341

A two-year lifestyle intervention study is recruiting more older adults at risk of dementia. The SINgapore GERiatric intervention study, or SINGER, aims to delay cognitive decline and physical frailty for those at risk. It involves intervention methods like cognitive training, nutritional guidance and exercise. Associate Professor Christopher Chen, director of the Memory Ageing and Cognition Centre at the National University Health System, discussed the types of intervention and the effective combinations in reducing the risk of dementia on CNA.

For full interview: https://www.youtube.com/watch?v=TZjvhKWwVHo

Channel 8 and Lianhe Zaobao reported on the NUHS lifestyle intervention study.  The SINgapore GERiatric intervention study, or SINGER, aims to delay cognitive decline and physical frailty for those at risk. The two-year study involves intervention methods like cognitive training, nutritional guidance and exercise.  Since August 2021, NUHS had recruited more than 350 participants, and recruitment was expected to continue until the end of 2023.

Channel 8 article: https://www.8world.com/singapore/nuh-dementia-study-1935181

Zaobao article: https://www.zaobao.com.sg/news/singapore/story20221005-1319617